Zambia has been picked as one of the five countries in the world by the United States Government to be supported with procurement of a long acting injectable ARV called cabotegravir (CAB-LA) this year.

Ministry of Health Director for Infectious Diseases Lloyd Mulenga says Zambia will this year receive the long-acting ARV which is a new injectable ARV offered  for prevention of HIV among people at high risk of acquiring the virus.

Speaking on the side-lines of the US government led Country Operating Planning for 2023/24 COP 23 Meeting in South Africa, Prof Mulenga said it is a safe and highly effective preventive option for people at substantial risk of HIV infection.

“The Ministry of health is doing everything possible to ensure reduction of new HIV infections the country”, Prof Mulenga added.